Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04855929 |
| Title | A Study Evaluating Safety and Therapeutic Activity of ANV419 in Patients With Advanced Cancer and Multiple Myeloma. (ANV419-001) |
| Acronym | ANV419-001 |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Anaveon AG |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | GBR | ESP | CHE |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Hospital Vall d'Hebrón | Barcelona | Spain | Details | |||
| START Madrid, Hospital Universitario HM Sanchinarro | Madrid | Spain | Details | |||
| University Hospital Basel | Basel | Switzerland | Details | |||
| Cantonal Hospital St.Gallen | Saint-Gall | Switzerland | Details | |||
| Royal Marsden Hospital | London | United Kingdom | Details |